Webcast CME

How to Obtain AMA PRA Category 1 Credit

  1. Watch the Activity.
  2. Answer the CME polling questions within the webcast.
  3. Log into your myCME account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.
  6. Credit can only be claimed once for this activity.

Technical Requirements

Advances in Biologic Therapies

 

Optimizing Co-Management Best Practices
for Psoriatic Diseases

Print this Content

Release Date:   September 22, 2016
Expiration Date:   September 22, 2018

Estimated Time of Completion:   30 minutes

Description

Advances in Biologic Therapies is a webcast series that provides clinicians with a review of the use of biologic agents in the fields of rheumatology, dermatology, allergy, and infectious disease.

This webcast reviews a psoriatic disease case with the expert, highlighting the cooperation between dermatology and rheumatology in the optimization of outcomes in skin and joint disease.

Learning Objectives

  1. Highlight the collaboration between dermatology and rheumatology in the optimization of outcomes in patients with complex inflammatory disease.
  2. Define TNF-induced psoriasis as a recognized adverse class effect of TNF-inhibitors.
  3. Review treatment options for TNF-induced psoriasis based on individual clinical features.
  4. Highlight the challenges in diagnosing psoriatic arthritis.

Target Audience

These activities are directed to rheumatologists, dermatologists, allergists, infectious disease practitioners, internal medicine physicians, pulmonologists, nurse practitioners, physician assistants, and other health care professionals caring for patients with immunologic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic
Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Anthony Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Department of Anatomic Pathology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair of Rheumatology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:


Leonard H. Calabrese, DO
  GSK, Pfizer, Inc., Sanofi Aventis, UCB Consulting

AbbVie Pharmaceuticals, BMS, Genentech/Roche, Janssen Consulting; Teaching and Speaking

Crescendo
Teaching and Speaking
M. Elaine Husni, MD, MPH
  Abbvie Pharmaceuticals, Janssen, Novartis Pharmaceuticals, UCB Consulting

Amgen, BMS Consulting, Membership on advisory committee or review panels

Celgene Corporation, Lilly, Pfizer, Inc.
Membership on advisory committee or review panels

The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Anthony Fernandez, MD, PhD


The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:


AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb
Exagen Diagnostics
Genentech, Inc.
Pfizer, Inc.

This CME activity was produced by Cleveland Clinic Center for Continuing Education and
R.J. Fasenmyer Center for Clinical Immunology.

 
Copyright © 2000-2016 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124
Copyright © 2000-2016 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124